(Q38593722)

English

The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials

scientific article published on 25 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Gabriella Passacquale

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Paolo Di Giosia

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 September 2015

1 reference

Europe PubMed Central

4 September 2017

Cardiovascular Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

9-23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Anti-inflammatory therapies for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocytes in coronary artery disease and atherosclerosis: where are we now?

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inflammatory biomarkers for predicting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Comparison of gene expression profiles between human and mouse monocyte subsets

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Monocyte and macrophage heterogeneity

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Fractalkine preferentially mediates arrest and migration of CD16+ monocytes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Macrophage plasticity in experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

The safety and immunogenicity of a CETP vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Co-administration of a CpG adjuvant (VaxImmune, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Heat shock protein 60 and immune inflammatory responses in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV227

21 January 2018

Identifiers

10.1093/CVR/CVV227

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26410367%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38593722&oldid=1769238216"